Commercially available tests for determining cefiderocol susceptibility display variable performance in the Achromobacter genus

• Main Authors: Vincent Jean-Pierre (Author), Pauline Sorlin (Author), Katy Jeannot (Author), Raphaël Chiron (Author), Jean-Philippe Lavigne (Author), Alix Pantel (Author), Hélène Marchandin (Author)
• Format: Book
• Published: BMC, 2024-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Cefiderocol is a siderophore-conjugated cephalosporin increasingly used in the management of Achromobacter infections. Testing for cefiderocol susceptibility is challenging with distinct recommendations depending on the pathogens. Objectives We evaluated the performance of commer...